ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $21.0B
- YoY, 2025
- +4.8%
- 5-year CAGR
- +3.8%
- 10-year CAGR
- +5.3%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $21.0B | +4.8% |
| 2024 | $20.0B | −0.3% |
| 2023 | $20.1B | +13.5% |
| 2022 | $17.7B | +11.2% |
| 2021 | $15.9B | −8.8% |
| 2020 | $17.5B | +30.6% |
| 2019 | $13.4B | −4.7% |
| 2018 | $14.0B | +10.8% |
| 2017 | $12.7B | +0.7% |
| 2016 | $12.6B | +0.2% |
| 2015 | $12.5B | +6.7% |
| 2014 | $11.7B | +18.0% |
| 2013 | $10.0B | +14.7% |
| 2012 | $8.7B | +2.9% |
| 2011 | $8.4B | −3.4% |
| 2010 | $8.7B | −3.2% |
| 2009 | $9.0B | +6.1% |
| 2008 | $8.5B | −2.3% |
| 2007 | $8.7B | — |